Merrimack Pharmaceuticals Inc Share Price Nasdaq
Equities
US5903281005
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 192M 16.03B |
---|---|---|---|---|---|
Net income 2022 | -1M -83.46M | Net income 2023 | -1M -83.46M | EV / Sales 2022 | - |
Net cash position 2022 | 19.44M 1.62B | Net cash position 2023 | 18.88M 1.58B | EV / Sales 2023 | - |
P/E ratio 2022 |
-100
x | P/E ratio 2023 |
-162
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.79% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 01/93/01 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 01/04/01 |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 01/04/01 |
Director/Board Member | 45 | 19/19/19 | |
Ulrik Nielsen
FOU | Founder | 52 | 01/93/01 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |